NEW YORK, June 16 (GenomeWeb News) - Alnylam has amended its exclusive license of an RNAi patent application from the Max Planck Society, freeing it from certain obligations to maintain jobs and facilities in Germany, the company said today.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.